SANTA CLARA, Calif.----XenoPort, Inc. announced today financial results for the third quarter and nine months ended September 30, 2009. Revenues for the third quarter were $0.4 million, compared to $4.9 million for the same... [read full story]
|
RELATED
|
|
XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2009. Revenues for the third quarter were $0.4 million, compared to $4.9 million for the same period in...
Investing & Markets, Scientific Discoveries, General Management Issues, Health Care, Finance, Banking & Insurance, Ambulatory Health Care, Research & Development, Patients, Financial Markets, Stock Markets, Medical Research, Pain, Drowsiness, GlaxoSmithKline, XenoPort, Astellas Pharma, United States of America, Bay Area (California), California, North America, Santa Clara (California), Japan
